Modes of action of low-dose cabazitaxel in combination with the antiangiogenic and antitumoral pigment epithelium-derived factor in prostate cancer.
Year: 2017
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Texas Tech University Health Sciences Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2601706262
